Sign In
Buy ASRT
$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
ASRT vs. ZTS: Which Stock Is the Better Value Option?
12:47pm, Monday, 13'th Jun 2022
ASRT vs. ZTS: Which Stock Is the Better Value Option?
New Strong Buy Stocks for June 10th
08:17am, Friday, 10'th Jun 2022
SBLK, SSB, HCI, ASRT, and TTI have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2022.
7 Best Penny Stocks to Buy Now for Moonshot Potential
06:25am, Friday, 10'th Jun 2022
In a tough 2022 year for the stock market, these penny stocks could be on the cusp of market-beating gains. The post 7 Best Penny Stocks to Buy Now for Moonshot Potential appeared first on InvestorPla
New Strong Buy Stocks for June 7th
08:17am, Tuesday, 07'th Jun 2022
SBLK, GOGL, LPX, ASRT, and CC have been added to the Zacks Rank #1 (Strong Buy) List on June 7, 2022.
Are Medical Stocks Lagging Assertio (ASRT) This Year?
11:18am, Monday, 30'th May 2022
Here is how Assertio (ASRT) and UnitedHealth Group (UNH) have performed compared to their sector so far this year.
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
12:48pm, Thursday, 26'th May 2022
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Assertio's Phenomenal Turnaround
02:38am, Thursday, 19'th May 2022
The company has made giant strides in putting its financials in order, getting rid of almost $1B in debt and its net debt has been all but eliminated. We believe more is to come as the company's all-d
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
11:17am, Friday, 13'th May 2022
Here is how Assertio (ASRT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.
Assertio Posts Higher Q1 Sales, Profits; Lifts FY22 Adjusted EBITDA Outlook
02:48pm, Tuesday, 10'th May 2022
Assertio Holdings Inc (NASDAQ: ASRT) posted Q1 sales of $35.5 million, up 37% Y/Y, surpassing the consensus of $33.06 million. The increase was primarily driven by higher net pricing on Indocin and
Assertio Holdings, Inc. (ASRT) CEO Daniel Peisert on Q1 2022 Results - Earnings Call Transcript
09:59pm, Monday, 09'th May 2022
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Max Nemmers - Head, Investor Relations and Administration Daniel Peisert - President
Assertio (ASRT) Surpasses Q1 Earnings and Revenue Estimates
06:49pm, Monday, 09'th May 2022
Assertio (ASRT) delivered earnings and revenue surprises of 122.22% and 10.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Assertio Holdings, Inc. to Report First Quarter 2022 Financial Results After the Close of Markets on Monday, May 9, 2022
09:00am, Friday, 22'nd Apr 2022
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release first quarter 2022 financial r
Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?
06:04pm, Wednesday, 13'th Apr 2022
Here is how Assertio (ASRT) and Histogen Inc (HSTO) have performed compared to their sector so far this year.
Best Value Stocks to Buy for April 13th
07:32am, Wednesday, 13'th Apr 2022
WFG, GOGL, and ASRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 13, 2022.
JAZZ Inks Deal With Werewolf to Add Oncology Candidate
03:48pm, Friday, 08'th Apr 2022
Jazz (JAZZ) signs an agreement to gain rights to Werewolf's engineered cytokine pro-drug candidate WTX-613. The candidate has the potential to treat a wide range of cancer types.
